Mersana Therapeutics Inc.

NASDAQ: MRSN · Real-Time Price · USD
7.14
-0.28 (-3.77%)
At close: Aug 15, 2025, 3:59 PM
7.44
4.20%
After-hours: Aug 15, 2025, 06:16 PM EDT

Mersana Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-2.53 -1.57 -2.64 -2.59
PEG Ratio
0.04 0.05 0.28 -0.04
PS Ratio
4.33 7.31 20.65 10.21K
PB Ratio
-18.43 7.30 5.96 3.61
P/FCF Ratio
-2.12 -1.57 -10.64 -3.12
P/OCF Ratio
-2.13 -1.6 -11.12 -3.14
OCF/S Ratio
-2.03 -4.58 -1.86 -3.26K
Debt / Equity Ratio
-3.01 0.92 0.39 0.31
Quick Ratio
2.19 3.36 3.49 3.97
Current Ratio
2.19 3.36 3.49 3.97
Asset Turnover
0.28 0.16 0.08 0.00
Interest Coverage
-18.93 -41.97 -61.51 -133.95
Return on Equity
7.28 -4.65 -2.25 -1.39
Return on Assets
-0.48 -0.76 -0.62 -0.82
Return on Invested Capital
-0.75 -1.02 -0.85 -1.05
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.96 -3.02 0.97 -3.07K
Net Profit Margin
-1.71 -4.66 -7.81 -3.94K
Pretax Profit Margin
-1.7 -4.66 -7.68 -3.95K
Operating Profit Margin
-1.81 -4.64 -7.7 -3.95K
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-1.56 -4.51 -7.52 -3.91K